And some researchers hoped that the drugs could also help with some of the most difficult diseases to treat — those of the brain, like Parkinson’s. But now, at least for Parkinson’s ...
By Alex Marshall Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, said Thursday that he has Parkinson’s disease.
“But his voice is as good as it’s ever been,” Sharon Osbourne says of her husband The Osbournes/Youtube Ozzy Osbourne can no longer walk as his health continues to be impacted by Parkinson ...
This is one of the first studies to examine whether sensory impairments, such as hearing loss, might increase the risk for Parkinson's or serve as an early warning sign. Parkinson's UK reports ...
Get Instant Summarized Text (Gist) A key regulator for the GTPase function of the LRRK2 gene, linked to Parkinson's Disease, has been identified. This regulator, CalDAG-GEFI, can control the ...
This is not the kind of honor I ever anticipated on my life bingo card. But I never expected a Parkinson’s disease diagnosis, either. Or starting a foundation that bears my name, which has ...
A pattern of land acquisitions tied to SAS raises questions about the tech giant's plans in Cary. STORY HIGHLIGHTS Reedy Creek Investments bought land near SAS headquarters in Cary. SAS CEO Jim ...
Jan. 14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according to new research. This is one of the first studies to examine whether ...
The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify biomarkers of Parkinson’s disease well in advance of symptoms appearing.
Delray Medical Center cut the ribbon on its newest high-tech machine last week that targets brain areas to treat movement disorders such as essential tremor and tremor-dominant Parkinson’s disease.
Previous studies suggest GLP-1 receptor agonists may benefit those with Parkinson’s disease. A phase 3 randomized controlled trial found no significant improvements with the GLP-1 exenatide in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results